Farther Finance Advisors »

Entrada Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $229 17 13.47

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Dimensional International Value Etf Etf (DFIV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Schwab U.s. Large-cap Etf Etf (SCHX)
Microsoft Corp Stock (MSFT)
Vanguard Value Etf Etf (VTV)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Amazon Stock (AMZN)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Ishares 0-5 Year Tips Bond Etf Etf (STIP)

View all positions for Farther Finance Advisors

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Wellington Management Company
StepStone
Geode Capital Management
State Street Corporation
Millennium Management
Jacobs Levy Equity Management
Acadian Asset Management
Citadel Advisors
Dimensional Fund Advisors
Renaissance Technologies

View all funds holding Entrada Therapeutics